activesellsec_filings

TER 10-Q report for 2025-09-28

Teradyne (TER) filed its Form 10‑Q for the quarter ended September 28, 2025. The filing includes condensed consolidated financial statements, MD&A reference, and notes — showing nine‑month revenues of $2,106.7 million and net income of $296.8 million, a decline in cash and cash equivalents versus year‑end, and new short‑term borrowings.

Confidence
60 / 100
Assets
1
Authors
1
Outcome
open

Linked assets

TER — Teradyne, Inc. (Nasdaq: TER). The filing confirms issuer identifiers, shares outstanding, and detailed interim financial statements for the three and nine months ended September 28, 2025.

TERsellopen

Teradyne filed its Form 10‑Q for the quarter ended September 28, 2025. The condensed consolidated financial statements show total revenues of $769.2 million for the three months and $2,106.7 million for the nine months ended September 28, 2025. Net income was $119.6 million for the quarter and $296.8 million for the nine months. Cash and cash equivalents declined to $272.7 million at September 28, 2025 (from $553.4 million at December 31, 2024). The balance sheet shows $200.0 million of short-term debt recorded at quarter end and total assets of $3,963.7 million.

Confidence: 60 / 100Start: $176.88Latest: $351.47Return: -98.71%

The 10‑Q provides audited interim financials and footnote context: nine‑month revenues of $2,106.7 million and net income of $296.8 million; quarter revenues of $769.2 million and net income of $119.6 million. Key balance-sheet movements include cash & cash equivalents falling to $272.7 million (from $553.4 million at 12/31/2024), inventories of $366.8 million, and a $200.0 million short‑term borrowing on the credit facility. Share count information and EPS (basic nine‑month EPS $1.85; diluted $1.85) are provided. The filing is actionable primarily as an authoritative source of interim financials and capital‑structure details; it does not by itself establish a high‑confidence directional trading catalyst without additional market context.

Source proof

Source proof: Strong source proof | 1 directional asset | 1 supporting author | headline-like title review

This play is sourced from Teradyne’s Form 10‑Q covering the quarter ended September 28, 2025. The filing contains Condensed Consolidated Balance Sheets, Statements of Operations, Statements of Cash Flows and Notes to the Condensed Consolidated Financial Statements.

SNBR 10-Q report for 2026-04-04
Sleep Number Corp · May 12, 2026, 3:06 AM EDT

This excerpt is only the cover page/header of Sleep Number’s Form 10-Q for the quarter ended April 4, 2026. It contains filing metadata (issuer, ticker, exchange, address) but no financial statements, MD&A, guidance, risks, or operational commentary. As a result, it is not directly actionable for trading beyond confirming the filing exists.

View source
SOUN 10-Q report for 2026-03-31
SOUNDHOUND AI, INC. · May 11, 2026, 5:28 PM EDT

The provided excerpt is only the cover/filing header of SoundHound AI, Inc.’s 10‑Q for the quarter ended 2026‑03‑31. It contains listing/security identifiers (SOUN, SOUNW) but no financial statements, MD&A, guidance, risk updates, liquidity details, or material events. As a result, there is insufficient information to form high-confidence, actionable bullish/bearish theses beyond generic “company filed its 10‑Q” metadata.

View source
WEAT 10-Q report for 2026-03-31
Teucrium Commodity Trust · May 11, 2026, 5:19 PM EDT

The provided excerpt is only the boilerplate cover/filing-status section of Teucrium Commodity Trust’s Form 10‑Q for period ended 2026‑03‑31, with no portfolio holdings, performance, risk, or material updates included. As-is, it contains no actionable investment information beyond confirming the existence of the filing and the issuer/ticker identity (WEAT).

View source
ACHR 10-Q report for 2026-03-31
Archer Aviation Inc. · May 11, 2026, 5:01 PM EDT

The provided excerpt is only the cover/header portion of Archer Aviation’s Form 10‑Q for the quarter ended 2026‑03‑31 (issuer identity, exchange listing, and securities outstanding). It contains no operating/financial results, guidance, liquidity details, backlog, or risk-factor updates—so it is minimally actionable for trading beyond basic security identifiers and a generic dilution/optionality consideration from warrants.

View source
CLSK 10-Q report for 2026-03-31
CLEANSPARK, INC. · May 11, 2026, 4:58 PM EDT

This excerpt is essentially the cover page of CleanSpark, Inc.’s Form 10-Q for the quarter ended March 31, 2026. It contains identifiers (CIK/file no.), listing venue, and security descriptions (common stock and redeemable warrants with specific exercise terms), but no operating/financial results, guidance, risks, or MD&A detail. Actionability is therefore limited to capital-structure/dilution considerations around the listed warrant.

View source
ASTS 10-Q report for 2026-03-31
AST SpaceMobile, Inc. · May 11, 2026, 4:40 PM EDT

This excerpt of AST SpaceMobile’s 10‑Q is largely SEC cover-page/boilerplate (registrant info, exchange listing, filing compliance) and contains no financial results, guidance, liquidity, risk-factor updates, or operating metrics. As provided, it does not create a clear tradable catalyst beyond confirming continued reporting/listing status.

View source
SMCI 10-Q report for 2026-03-31
Super Micro Computer, Inc. · May 11, 2026, 4:38 PM EDT

This excerpt only includes the cover page of Super Micro Computer, Inc.’s Form 10‑Q for the quarter ended March 31, 2026. It confirms the filing, issuer identity, listing (Nasdaq), and ticker (SMCI), but contains no financial results, guidance, risks, or MD&A content to support a directional investment view.

View source
ABCL 10-Q report for 2026-03-31
AbCellera Biologics Inc. · May 11, 2026, 4:18 PM EDT

The provided text is only the cover/header portion of AbCellera Biologics Inc.’s Form 10‑Q for the quarter ended March 31, 2026 (identifying info, exchange listing, filing status). It contains no financial statements, guidance, risk updates, material events, MD&A, cash runway, pipeline/program updates, or disclosures that would support a differentiated trading view.

View source

Supporting authors

Prepared from the company-filed Form 10‑Q. No external analyst commentary is included in the source excerpts.

Unlock full thesis monitoring

Review the 10‑Q to validate the figures below, then consider the recommended strategy and check for any subsequent company disclosures or market-moving events before trading.